| Officer | Age | In this role | 2025 pay | Source |
|---|---|---|---|---|
|
Joshua Pinto
Also a director
President & CEO
Title from the Form 4 dated Aug 20, 2026
|
42 |
Since 2025
1 year
|
$6,743,238 | |
|
Paul L. Berns
Also a director
See Remarks
Title from the Form 4 dated Aug 20, 2026
|
59 | Not stated | $4,562,461 | |
|
Jason Duncan
See Remarks
Title from the Form 4 dated Aug 20, 2026
|
52 | Not stated | Not reported | |
|
Daljit (Bill) Singh Aurora
See Remarks
Title from the Form 4 dated Aug 20, 2026
|
58 | Not stated | Not reported | |
|
Michael Milligan
See Remarks
Title from the Form 4 dated Aug 20, 2026
|
54 | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 17, 2026 · updated by the 8-K of Aug 14, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Paul L. Berns
Board chair
|
59 |
2020
6 years
|
Not independent | None stated | None stated | Not stated | |
|
Matthew Fust
|
61 |
2020
6 years
|
Not stated | None stated | None stated | $134,257 | |
|
David Piacquad
|
69 |
2023
3 years
|
Not stated |
Audit Committee
|
None stated | $97,382 | |
|
Kristina Burow
|
52 |
2020
6 years
|
Not stated | None stated | Boundless Bio, Beam Therapeutics, Scholar Rock | $111,132 | |
|
Alaa Halawa
|
43 |
2022
4 years
|
Not stated | None stated | None stated | $106,132 | |
|
Maykin Ho
|
73 |
2021
5 years
|
Not stated |
Audit Committee
|
Agios Pharmaceuticals, BioMarin Pharmaceutical, FibroGen | Not stated | |
|
Joshua Pinto
Joined Aug 14, 2026
|
- | - | - | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 17, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...